+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma



Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma



World Neurosurgery 80(3-4): 359-363



For multisession radiosurgery, no published data relate the volume and dose of cochlear irradiation to quantified risk of hearing loss. We conducted a retrospective, dosimetric study to evaluate the relationship between hearing loss after stereotactic radiosurgery (SRS) and the dose-volume of irradiated cochlea. Cochlear dose data were retrospectively collected on consecutive patients who underwent SRS (18 Gy in 3 sessions) for vestibular schwannoma between 1999 and 2005 at Stanford University Hospital. Inclusion criteria included Gardner-Robertson (GR) grade I or II hearing prior to radiosurgical treatment, complete audiograms, and magnetic resonance imaging (MRI) follow-up. A cochlea dose-volume histogram was generated for each of the 94 patients who qualified for this study. GR grade I-II hearing posttreatment was maintained in 74% of patients (70/94). Median time to last follow-up audiogram was 2.4 years (range 0.4-8.9) and to last MRI was 3.6 years (range 0.5-9.4). Each higher level of cochlear irradiation was associated with increased risk of hearing loss. Larger cochlear volume was associated with lower risk of hearing loss. Controlling for differences in cochlear volume among subjects, each additional mm(3) of cochlea receiving 10 to 16 Gy (single session equivalent doses of 6.6-10.1 Gy3) significantly increased the odds of hearing loss by approximately 5%. Larger cochlear volume is associated with lower risk of hearing loss following trisession SRS for vestibular schwannoma. Controlling for this phenomenon, higher radiation dose and larger irradiated cochlear volume are significantly associated with higher risk of hearing loss. This study confirms and quantifies the risk of hearing loss following trisession SRS for vestibular schwannoma.

(PDF emailed within 0-6 h: $19.90)

Accession: 052153545

Download citation: RISBibTeXText

PMID: 22484770

DOI: 10.1016/j.wneu.2012.04.001


Related references

Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma. Journal of Neurological Surgery. Part B, Skull Base 79(4): 335-342, 2018

Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. Journal of Neurosurgery 118(3): 579-587, 2013

Asymmetric sensorineural hearing loss caused by vestibular schwannoma: Characteristic imaging features before and after treatment with stereotactic radiosurgery. Radiology Case Reports 5(2): 437, 2010

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. Radiation Oncology 13(1): 253-253, 2018

Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma. Journal of Neurological Surgery. Part B, Skull Base 80(2): 156-164, 2019

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?. Journal of Neurosurgery 109 Suppl: 129-136, 2009

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?. Journal of Neurosurgery 119 Suppl: 129-136, 2014

Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. Journal of Clinical Neuroscience 16(6): 742-747, 2009

Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 104(3): 580-590, 2005

Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. International Journal of Radiation Oncology, Biology, Physics 100(2): 443-451, 2017

Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing. Advances and Technical Standards in Neurosurgery 2016(43): 3-36, 2016

Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report. Neurosurgery 45(6): 1299-305; Discussion 1305-7, 1999

Vestibular Schwannoma: The Evolution of Hearing and Tumor Size in Natural Course and after Treatment by LINAC Stereotactic Radiosurgery. Audiology and Neuro-Otology 20(6): 406-415, 2016

Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients-A Retrospective Cohort Study. Neurosurgery 2018, 2018

Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) Practice Guideline. Journal of Radiosurgery and Sbrt 5(1): 5-24, 2018